Karolinska Development AB
No trades
−0.043377 USD
−729.09 K USD
521.55 K USD
372.59 M
About KDventures AB Class B
Sector
Industry
CEO
Viktor Drvota
Website
Headquarters
Solna
Founded
2006
IPO date
Apr 15, 2011
Identifiers
2
ISIN SE0002190926
KDventures AB engages in the investment in pharmaceutical and medical technology companies. Its portfolio investments include Umecrine Cognition, Forendo Pharma, OssDsign, Modus Therapeutics, Dilafor, Aprea Therapeutics, Lipidor, Promimic, and Asarina Pharma. The company was founded in 2003 and is headquartered in Solna, Sweden.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of KDEVF is 0.257600 USD — it has decreased by −58.00% in the past 24 hours. Watch Karolinska Development AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Karolinska Development AB stocks are traded under the ticker KDEVF.
KDEVF reached its all-time high on Apr 5, 2019 with the price of 0.613282 USD, and its all-time low was 0.257600 USD and was reached on Jun 22, 2022. View more price dynamics on KDEVF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
KDEVF stock is 138.08% volatile and has beta coefficient of 0.38. Track Karolinska Development AB stock price on the chart and check out the list of the most volatile stocks — is Karolinska Development AB there?
Today Karolinska Development AB has the market capitalization of 29.72 M, it has decreased by −7.65% over the last week.
Yes, you can track Karolinska Development AB financials in yearly and quarterly reports right on TradingView.
KDEVF net income for the last quarter is −7.07 M USD, while the quarter before that showed −7.71 M USD of net income which accounts for 8.30% change. Track more Karolinska Development AB financial stats to get the full picture.
No, KDEVF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Karolinska Development AB EBITDA is −14.30 M USD, and current EBITDA margin is −140.83%. See more stats in Karolinska Development AB financial statements.
Like other stocks, KDEVF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Karolinska Development AB stock right from TradingView charts — choose your broker and connect to your account.